Neu Hepatitis C: Effektives klinisches Management im Zeitalter der oralen Therapie...
53,67 €
Fueled in part by the opioid epidemic, the number of reported hepatitis C virus infections tripled in the United States between 2010 and 2015. As new infections continue to mount, new therapies have produced seismic changes in how HCV is treated clinically, leaving a gap between the most current clinical guidance and the ongoing demands of patient care.
Jetzt bei Ebay:
